Product Information
ATROPINE 1% EYE DROPS is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $11.5149 per ML under NDC 60219174802. Its NADAC has been published 204 times since Nov 9, 2022.
FDA first approved this application on Jul 14, 2022. Its Orange Book therapeutic-equivalence code is AT1.
Strength
10 mg/mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219174802
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
ATROPINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA214752FDA Approved
7/14/2022
TE Code
AT1
On Market Since
7/19/2022
Pharmacological Classes
Price Statistics
The NADAC for ATROPINE 1% EYE DROPS has been published 204 times since Nov 9, 2022, and over the history we have for it it has declined 35.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5149 per ML |
|---|---|
| All-time high | $17.8332 (Nov 16, 2022) |
| All-time low | $9.4650 (May 22, 2024) |
| 52-week high | $13.3034 |
| 52-week low | $11.5149 |
| Median price | $13.3034 |
| Average price | $13.8546 |
| Largest weekly change | +36.2% (Jun 19, 2024) |
| Weeks tracked | 204 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atropine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATROPINE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ATROPINE 1% EYE DROPS, manufactured by Amneal Pharmaceuticals NY LLC, is $11.5149 per ML (NDC 60219174802), effective Sep 30, 2026.
How has the price of ATROPINE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ATROPINE 1% EYE DROPS has declined 35.4%. It has been tracked across 204 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for ATROPINE 1% EYE DROPS?
Since Nov 9, 2022, the NADAC for ATROPINE 1% EYE DROPS has ranged from a low of $9.4650 (May 22, 2024) to a high of $17.8332 (Nov 16, 2022), with a median of $13.3034 per ML.
Are there cheaper alternatives to ATROPINE 1% EYE DROPS?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATROPINE 1% EYE DROPS, is $4.1619 per ML — about 64% below ATROPINE 1% EYE DROPS.
Who manufactures ATROPINE 1% EYE DROPS?
ATROPINE 1% EYE DROPS (NDC 60219174802) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.